Compare Intikeramik Alamasri Industri Tbk. (IKAI) vs Charlie Hospital Semarang Tbk. (RSCH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Intikeramik Alamasri Industri Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Intikeramik Alamasri Industri Tbk. trades at Rp21 (market cap 279.42B, 5.2M 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp312 (market cap 821.5B, 25.59M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is far larger — about 2.9× Intikeramik Alamasri Industri Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (25.59M versus 5.2M). Which is the better fit depends on your goals.
| IKAI | RSCH | |
|---|---|---|
Market Cap | 279.42B | 821.5B |
Volume | 5.2M | 25.59M |
Lot | 52.01K | 255.95K |
Turnover | 108.1M | 7.95B |
Average Price | 20.79 | 310.77 |
Value | 108.1M | 7.95B |
Indicative Equilibrium Price | 21 | 312 |
Indicative Equilibrium Volume | 8.02K | 10 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Intikeramik Alamasri Industri Tbk.
PT Intikeramik Alamasri Industri Tbk (the Company) was established under the name PT Intikeramik Alamasri Indah based on notarial deed No. 38 dated June 26, 1991 and was amended with notarial deed No. 16 dated December 14, 1991, both made by Raden Muhammad Hendarmawan, S.H., Notary in Jakarta. PT Intikeramik Alamasri Industri Tbk is the pioneer of large-scale porcelain tile manufacture in Indonesia and one of the largest producers in the Asia Pacific region. Porcelain tiles are superior in term of strength, durability and design versatility to natural stone as well as other synthetics such as glazed tiles. Porcelain is attractive and affordable for use in both commercial and residential developments and has strong following among international architects and interior designers. Intikeramik is seeking to build a leading profile in markets across Europe, America and Asia drawing upon its reputation for consistency, advanced manufacturing technology, a low cost base and substantial available capacity. The company has consolidation production capacity 6,600,000 m2 /year.
Read more on IKAI →About Charlie Hospital Semarang Tbk.
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →
